| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000021688 |
| Receipt No. | R000025018 |
| Official scientific title of the study | the evaluation of the appropriate dose of dexmedetomidine under Sedline which is the new monitoring for the degree of sedation |
| Date of disclosure of the study information | 2016/03/31 |
| Last modified on | 2018/12/10 (Ver. 6) |
| Basic information | ||
| Official scientific title of the study | the evaluation of the appropriate dose of dexmedetomidine under Sedline which is the new monitoring for the degree of sedation | |
| Title of the study (Brief title) | the evaluation of the appropriate dose of dexmedetomidine under Sedline which is the new monitoring for the degree of sedation | |
| Region |
|
|
| Condition | |||
| Condition | the patients proposed operation under local anesthesia | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | We compare the degree of sedation by middle dose of dexmedetomidine with minimum dose of it during using Sedline which is the monitoring for evaluation of the degree of sedation |
| Basic objectives2 | Pharmacokinetics |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | the change of the degree of sedation, respiratory rate, oxygenation, systolic blood pressure and heart rate at every 15 minutes, and RASS score at the operation finished |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Dose comparison |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 2 | ||
| Purpose of intervention | Treatment | ||
| Type of intervention |
|
||
| Interventions/Control_1 | low dose of dexmedetomidine group: 6 microgram/kg /hr dexmedetomidine was administered over a period of 10 minutes as a loading dose, and then maintenance infusion (0.2 microgram/kg/hr) was started. | ||
| Interventions/Control_2 | middle dose of dexmedetomidine group: 6 microgram/kg /hr dexmedetomidine was administered over a period of 10 minutes as a loading dose, and then maintenance infusion (0.4 microgram/kg/hr) was started. | ||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | the patients which has ASA PS I or II and proposed operation under local anesthesia | |||
| Key exclusion criteria | the patients who has difficulty in mutual understanding , has difficulty to get cooperation, has cardiovascular or respiratory or neurological complication | |||
| Target sample size | 50 | |||
| Research contact person | |
| Name of lead principal investigator | Mitsutaka Edanaga |
| Organization | Sapporo Medical University School of Medicine |
| Division name | Department of Anesthesiology |
| Address | S1, W16, Chuo-ku, Sapporo, Hokkaido, Japan |
| TEL | 011-688-9663 |
| edanaka@sapmed.ac.jp | |
| Public contact | |
| Name of contact person | Kouji Hamaya |
| Organization | Sapporo Medical University School of Medicine |
| Division name | Hospital section |
| Address | S1, W16, Chuo-ku, Sapporo, Hokkaido, Japan |
| TEL | 011-611-2111 |
| Homepage URL | |
| ko-hamaya-923@sapmed.ac.jp | |
| Sponsor | |
| Institute | Sapporo Medical University School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Department of Anesthesiology, Sapporo Medical University School of Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025018 |